Advertisement
Advertisement
XGN
Exagen Inc. Common Stock
4.52
USDSponsored
+0.16
+3.79%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
4.50
-0.02
-0.53%
XGN Earnings Reports
Positive Surprise Ratio
XGN beat 21 of 27 last estimates.
78%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$17.96M
/-$0.18
Implied change from Q1 26 (Revenue/ EPS)
+3.80%
/-10.00%
Implied change from Q2 25 (Revenue/ EPS)
+4.43%
/+5.88%
Exagen Inc. Common Stock earnings per share and revenue
On May 11, 2026, XGN reported earnings of -0.20 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 15.15% surprise. Revenue reached 17.31 million, compared to an expected 16.58 million, with a 4.39% difference. The market reacted with a +34.92% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 17.96 million USD, implying an decrease of -10.00% EPS, and increase of 3.80% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Canopy Growth Corporation Common Shares
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.40
Surprise
-309.74%
High Tide Inc. Common Shares
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.01
Surprise
+135.97%
Aurora Cannabis Inc. Common Shares
Report Date
Jun 11, 2026 For Q4 26
Estimate
-$0.08
Actual
$0.11
Surprise
+228.06%
FAQ
What were Exagen Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Exagen Inc. Common Stock reported EPS of -$0.20, beating estimates by 15.15%, and revenue of $17.31M, 4.39% above expectations.
How did the market react to Exagen Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 34.92%, changed from $2.95 before the earnings release to $3.98 the day after.
When is Exagen Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for Exagen Inc. Common Stock's next earnings report?
Based on 9
analysts, Exagen Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $17.96M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement